Breast cancer statistics, 2015: Convergence of incidence rates between black and white women

By C. DeSantis, S. Fedewa, Ann Goding Sauer, J. Kramer, Robert A. Smith, A. Jemal. Ca, 2016

1,243 citations recorded by the source corpus.

In this article, the American Cancer Society provides an overview of female breast cancer statistics in the United States, including data on incidence, mortality, survival, and screening. Approximately 231,840 new cases of invasive breast cancer and 40,290 breast cancer deaths are expected to occur among US women in 2015. Breast cancer incidence rates increased among non‐Hispanic black (black) and Asian/Pacific Islander women and were stable among non‐Hispanic white (white), Hispanic, and American Indian/Alaska Native women from 2008 to 2012. Although white women have historically had higher incidence rates than black women, in 2012, the rates converged. Notably, during 2008 through 2012, incidence rates were significantly higher in black women compared with white women in 7 states, primarily located in the South. From 1989 to 2012, breast cancer death rates decreased by 36%, which translates to 249,000 breast cancer deaths averted in the United States over this period. This decrease in death rates was evident in all racial/ethnic groups except American Indians/Alaska Natives. However, the mortality disparity between black and white women nationwide has continued to widen; and, by 2012, death rates were 42% higher in black women than in white women. During 2003 through 2012, breast cancer death rates declined for white women in all 50 states; but, for black women, declines occurred in 27 of 30 states that had sufficient data to analyze trends. In 3 states (Mississippi, Oklahoma, and Wisconsin), breast cancer death rates in black women were stable during 2003 through 2012. Widening racial disparities in breast cancer mortality are likely to continue, at least in the short term, in view of the increasing trends in breast cancer incidence rates in black women. CA Cancer J Clin 2016;31–42. © 2015 American Cancer Society.

Subfields: Oncology

View Paper: https://www.semanticscholar.org/paper/c5ee5b8ada05cb73b84a24148a5f5ea6589670be

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Oncology

1. R. Siegel
2. A. Jemal
3. K. Miller
4. C. DeSantis
5. S. Fedewa
6. N. Almansour
7. F. Bray
8. Balázs Győrffy

Citations in the corpus

• Triple-Negative Breast Cancer: A Brief Review About Epidemiology, Risk Factors, Signaling Pathways, Treatment and Role of Artificial Intelligence (2022, background): “In addition, the mortality rate is significantly higher among black women, and black women are considered to have the lowest survival rates for malignancy (DeSantis et al., 2016).”
• Cancer statistics for African Americans, 2016: Progress and opportunities in reducing racial disparities (2016, background): “For example, 22% of breast cancers in black women are triple negative (estrogen receptor-negative, progesterone receptor-negative, and human epidermal growth factor receptor 2-negative) compared with 10% to 12% of those among women of other races/ethnicities in the United States.(45) These proportio”
• Risk Factors and Preventions of Breast Cancer (2017, background): “In North American, the 5-year relative survival rate of breast cancer patients is above 80% due to the timely detection of this disease [4].”
• Breast Cancer—Epidemiology, Risk Factors, Classification, Prognostic Markers, and Current Treatment Strategies—An Updated Review (2021, background): “In the United States, breast cancer alone is expected to account for 29% of all new cancers in women [6].”